https://www.thebodypro.com/category/adverse-events-comorbidities-hiv/tag/conference-coverage

The Latest

Cardiovascular Disease Indicators Not Higher Among HIV-Positive People on Long-Term Treatment Img

Cardiovascular Disease Indicators Not Higher Among HIV-Positive People on Long-Term Treatment

This study, presented at ICAAC 2014, found no difference in calcium scores -- a predictor of coronary artery disease -- between HIV-positive people on long-term antiretroviral therapy and the general population.

Only 10 Percent of Veterans With HCV or HCV/HIV in the U.S. Treated for HCV Img

Only 10 Percent of Veterans With HCV or HCV/HIV in the U.S. Treated for HCV

Only 1 in 10 veterans diagnosed with hepatitis C (HCV) or HIV/HCV coinfection in the Veterans Administration (VA) Medical Center got treated for HCV in a 2008-2013 analysis.

High Prevalence of COPD at Baseline in START Study Sub-Study Img

High Prevalence of COPD at Baseline in START Study Sub-Study

Chronic obstructive pulmonary disease (COPD) has been a leading cause of death globally (currently third highest) for at least the last 25 years. The main risk factor for COPD is cigarette smoking.

Risk of CVD or Type-2 Diabetes According to Change in BMI After Starting ART Img

Risk of CVD or Type-2 Diabetes According to Change in BMI After Starting ART

Initiation of antiretroviral therapy usually leads to increased weight and body mass index (BMI) that might be associated with an increased risk of cardiovascular disease and type-2 diabetes.

AIDS 2014: Mark Sulkowski on Hepatitis C Research (Video) Img

AIDS 2014: Mark Sulkowski on Hepatitis C Research (Video)

IFARA interviewed Mark Sulkowski, M.D., of Johns Hopkins University School of Medicine about new advances in hepatitis C screening and treatment.

COPD May Be Common and Underdiagnosed in People Living With HIV Img

COPD May Be Common and Underdiagnosed in People Living With HIV

Chronic obstructive pulmonary disease (COPD) was found in 9% of people living with HIV in a large French cohort -- and 77% of the cases were previously undiagnosed.

Hepatitis C Risk Among HIV-Negative Gay Men: Two Studies From ICAAC 2014 Img

Hepatitis C Risk Among HIV-Negative Gay Men: Two Studies From ICAAC 2014

Two studies examine the often overlooked hepatitis C (HCV) risk among HIV-negative men who have sex with men (MSM). While the incidence of HCV doesn’t appear to be great, screening is still uncommon and we may just be beginning to identify new cases....

Will There Ever Be a Hepatitis C Vaccine? Img

Will There Ever Be a Hepatitis C Vaccine?

Amidst the clamor and excitement of the ongoing hepatitis C (HCV) treatment renaissance, one word is rarely uttered: vaccine. But the hunt goes on, quietly -- and with great difficulty.

Hepatitis C Regimen, 3D, Cures 99% of Patients, With or Without Ribavirin Img

Hepatitis C Regimen, 3D, Cures 99% of Patients, With or Without Ribavirin

An oral, interferon-free combination of three drugs (ABT-450, ombitasvir and dasabuvir), administered with or without ribavirin, achieved a sustained virologic response 12 weeks post treatment (SVR12) in 99% of patients with chronic hepatitis C.

Short-Term Weight Gain Associated With Increase in CVD and Diabetes Post-ART in HIV Cohort Img

Short-Term Weight Gain Associated With Increase in CVD and Diabetes Post-ART in HIV Cohort

Data from a large cohort reveal much variability in mean weight gains after initiating ART, depending on the weight category before going on treatment.